Meet the University of Wisconsin-Madison’s Randolph Ashton Associate Professor of Biomedical Engineering |
Research area Bioengineering human stem cell-derived brain and spinal cord cells and tissues; commercial translation of RosetteArray® technology, which enables high-throughput screening of models of human brain and spinal cord development for toxicity testing and neurological disease modeling and drug discovery.
What excites you about your work?
“My lab’s research has the potential to transform medicine from treating the symptoms of neurodevelopmental disorders (e.g., Spina Bifida and Autism Spectrum Disorder) to preventing them all together or significantly mitigating their severity. This is incredibly exciting and motivates our consistent push to demonstrate and translate human stem cell-derived technologies that can be used for precision medicine applications.”
What do you hope to achieve?
“Through our bioengineered platforms that enable unprecedented access to and screening of models of human brain and spinal cord development, we hope to safeguard human wellness (toxicology applications) and potential (neurodevelopmental disorder modeling and drug discovery applications).”
Randolph’s work in stem cell bioengineering holds potential for groundbreaking research for neurodevelopmental disorders like Autism Spectrum Disorder, and we are excited to continue our partnership with the Ashton Lab.
– Andy DeTienne, WARF, Director of Licensing
Want to learn more?
Andy DeTienne, [email protected], 608.960.9857